Log In
BCIQ
Print this Print this
 

DAC-060

  Manage Alerts
Collapse Summary General Information
Company Genextra S.p.A.
DescriptionHDAC inhibitor
Molecular Target Histone deacetylase (HDAC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationSkin cancer
Indication DetailsTreat non-melanoma skin cancer (NMSC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today